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In this paper we develop a novel mathematical model of the insulin-TOR-MAPK signaling
network that controls growth. Most data on the properties of the insulin and MAPK
signaling networks are static and the responses to experimental interventions, such as
knockouts, overexpression, and hormonal input are typically reported as scaled quantities.
The modeling paradigm we develop here uses scaled variables and is ideally suited to
simulate systems in which much of the available data are scaled. Our mathematical
representation of signaling networks provides a way to reconcile theory and experiments,
thus leading to a better understanding of the properties and function of these signaling
networks. We test the performance of the model against a broad diversity of experimental
data. The model correctly reproduces experimental insulin dose-response relationships.
We study the interaction between insulin and MAPK signaling in the control of protein
synthesis, and the interactions between amino acids, insulin and TOR signaling. We study
the effects of variation in FOXO expression on protein synthesis and glucose transport
capacity, and show that a FOXO knockout can partially rescue protein synthesis capacity
of an insulin receptor (INR) knockout. We conclude that the modeling paradigmwe develop
provides a simple tool to investigate the qualitative properties of signaling networks.
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INTRODUCTION
Signaling through the insulin pathway is a major regulator of
growth in a broad diversity of vertebrates and invertebrates
ranging from humans and mice, to worms and flies (Oldham
and Hafen, 2003; Taniguchi et al., 2006; Sutter et al., 2007; So
et al., 2011). It regulates diverse processes such as blood glu-
cose homeostasis, differentiation, growth, and senescence (Tatar
et al., 2003). The pathway is also frequently misregulated in dis-
eases such as diabetes and different types of cancers. In some cells,
insulin regulates the uptake of glucose (Furtado et al., 2003), in
others it is a general regulator of protein synthesis and cell growth
(Colombani et al., 2003). Among the great discoveries is the inter-
action between insulin signaling and the Target of Rapamycin
(TOR), which mediates between the insulin signal and the uti-
lization of amino acids in protein synthesis and growth (Brogiolo
et al., 2001; Oldham and Hafen, 2003; Avruch et al., 2006; Grewal,
2009; Kim and Guan, 2011). The insulin network also interacts
with members of the FOXO family of transcriptional regulators
in the control of cell growth and cell proliferation (Jünger et al.,
2003; Puig et al., 2003; Southgate et al., 2007; Tang et al., 2011;
Snell-Rood and Moczek, 2012). The insulin signal is able to stim-
ulate upstream members of Ras/Raf-mediated MAPK cascades
(Seger and Krebs, 1995), which also lead to cellular growth.
Experimental work to understand the properties and function
of the insulin signaling network has tended to focus on the roles
of one or two components of the network at a time, for example
by knocking out or overexpressing one component and exam-
ining the phenotypic effect. The overall network is a conceptual
framework built up of a large set of individual experiences and
understandings. The network is becoming increasingly complex
and it is difficult to know how the various components interact
with each other. Experimentally, it is impractical, and in most
cases impossible, to control for all potential variables, nor is it
possible to determine to what degree an experimental result is a
consequence of the particular background in which it was per-
formed. Indeed, the functional consequence of a mutation is
largely dependent on the background in which it occurs (Dworkin
et al., 2009; Chandler et al., 2013). Alternatively, if the experi-
ment was done under highly controlled conditions, in vitro, on
a subset of the system, it is not possible to say how that subset
would actually perform when embedded within the more com-
plex network with all its many inputs, interactions, and feedback
loops. With very simple systems it is possible to perform thought
experiments that examine the logic of a network diagram by
simply stepping through it. But when the system is large, with
positive and negative feedback loops and a mixture of activat-
ing and inhibitory interactions, thought experiments generally
fail. In addition, although our understanding of the components
and overall structure of signal transduction networks is growing
rapidly, the dynamical properties of these networks remain largely
unknown. This is important because the explanation of some cel-
lular phenomenon lies not in the components but in the dynamics
of the system that led to the phenomenon (Wolkenhauer et al.,
2004).
A grasp of mechanics and combinatorial possibilities of
interactions between signaling molecules is insufficient for
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understanding cellular responses or changes in physiological
states. This is because the set of interactions that actually make
a functional difference to the cell are a small subset of all the
molecular interactions that occur; furthermore, detailed knowl-
edge of local interactions may not be sufficient to understand
the global dynamics of the network. Uncovering which compo-
nents and which dynamics are functionally important is one of
the most challenging and important questions for understanding
the function and evolution of these signaling networks.
One solution to understanding the properties of a complex
network is through mathematical modeling. A mathematical
model is nothing more than a quantitative, simplified abstraction
of the structure and kinetics of the system. It has two advantages:
one is that a mathematical model is completely explicit in what
is included and what is not, something an experimental system
seldom if ever can be, and second that it allows one to examine
whether the network elucidated by experimentation indeed has
the properties we assume it does.
There are many approaches to mathematical modeling.
Boolean models can describe the logic of a regulatory network,
differential equation models can describe the kinetics of a net-
work, and statistical models can describe the patterns of cor-
relation and covariance within a network. Several investigators
have developed differential equation-based mathematical models
for different portions of the insulin signaling network (Sedaghat
et al., 2002). Some of these models reproduce selected experimen-
tal data well (Sedaghat et al., 2002), while others do not attempt
to do so and are mostly concerned with the general or the for-
mal properties of the model mechanism (Alon, 2006; Vinod and
Venkatesh, 2009).
The most common problem encountered in building a mathe-
matical model is the dearth of data on the kinetics of the reactions.
Most data are static and record the response to an insulin stimu-
lus as “fold-activation” or “percent of control value” or “percent
of maximum response.” Thus response data are typically reported
as scaled quantities. The modeling paradigm we develop here
uses scaled variables and is ideally suited to simulate systems in
which much of the available data are scaled. We develop a sim-
ple network modeling paradigm, inspired by Boolean, genetic,
and neural network models (Reinitz and Sharp, 1995; Vohradsky,
2001; Jaeger et al., 2004; Faure et al., 2006; Martin et al., 2007),
that can be used to study the qualitative behavior of complex
networks, and apply it to a study of the insulin signaling net-
work. Abstracting the network in a way that is consistent with the
available data opens possibilities to reconcile experiments with
theory, and thus improves our understanding of the structure and
function of signaling networks. A well-validated mathematical
model is also a useful adjunct tool for the experimental biologist
because it allows for quick and inexpensive testing of alternative
hypotheses and may provide suggestions for experimental design.
METHODS
STRUCTURE OF THE NETWORK
The insulin signaling network we model is illustrated in
Figure 1. Insulin binds the insulin receptor (INR), causing it to
become phosphorylated and thus activated (Oldham and Hafen,
2003). INR has multiple phosphorylation sites which become
FIGURE 1 | Insulin and MAPK signaling network. The acronyms for the
components of the network and the rationale for the connectivity are
explained in the text.
autophosphorylated upon binding of insulin. The activated INR
recruits Insulin Receptor Substrate adaptor proteins (IRS) to
the cell membrane. The IRS proteins bind to phosophoinositide
3-kinase (PI3K) and to phosphatidylinositol(3,4,5)-triphosphate
(PIP3), and recruit both to the membrane. Biochemically, PI3K
becomes activated when it interacts with specific phosphotyrosine
motifs in the IRS (Taniguchi et al., 2006). Activated PI3K phos-
phorylates phosphatidylinositol(4,5)-biphosphate (PIP2, also at
the cell membrane) into PIP3. The tumor suppressor gene phos-
phatase tensin homolog deleted on chromosome 10 (PTEN)
catalyzes the opposite reaction, dephosphorylating PIP3 to
PIP2. PTEN reduces the amount of PIP3, a substrate neces-
sary for the activation of protein kinase B (PKB, also called
Akt) (Brazil and Hemmings, 2001). Through this mechanism,
PTEN is an antagonist to insulin signaling. PTEN is one of
the most commonly lost tumor suppressor genes in human
cancer. It has relatively high constitutive phosphatase activ-
ity (Leslie and Downes, 2004). PIP3 facilitates the phospho-
rylation of protein kinase C (PKC) by PDK1, thus activating
PKC (Standaert et al., 2001; Taniguchi et al., 2006). PIP3 also
causes an increase in autophosphorylation of PKC, indepen-
dent of PDK1, possibly by inducing conformational changes in
PKC (Standaert et al., 2001). PKC phosphorylates p70 ribo-
somal kinase S6K (Valovka et al., 2003). S6K is involved in
the regulation of cell cycle and growth (Montagne et al., 1999;
Valovka et al., 2003). S6K phosphorylates the ribosomal pro-
tein S6, and controls the translation of a class of mRNAs that
encode ribosomal proteins and elongation factors (Jefferies et al.,
1997).
PIP3 phosphorylates and activates PKB/Akt. PKB has several
targets including FOXO, a constitutively active transcription fac-
tor (Southgate et al., 2007) that is involved in the cellular response
to nutritional conditions (Gershman et al., 2007). When FOXO is
phosphorylated by PKB, it is translocated from the nucleus to the
cytoplasm, where it can no longer activate transcription (Essers
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et al., 2005; Aoyama et al., 2006). Under extreme starvation
conditions, FOXO upregulates the expression (but not the activa-
tion) of the INR, increasing cell sensitivity to insulin, and allowing
a fast response to insulin after feeding (Jünger et al., 2003; Puig
and Tijan, 2005).
PKB also activates TOR, a serine/threonine kinase that reg-
ulates growth in response to nutritional conditions. TOR is
required for response to amino acids (Hara et al., 1998). TOR
is activated by PKB and positively regulates cell growth via two
principal targets, S6K and 4E-BP (Hay and Sonenberg, 2004;
Sarbassov et al., 2005). S6K also phosphorylates the INR, decreas-
ing the interaction of INR with its substrate (IRS) and inhibiting
insulin signaling (Harrington et al., 2005). The proximal reg-
ulator of TOR is a small GTPase, Ras homology enriched in
brain (Rheb), which binds to the TOR catalytic domain and
activates TOR (Avruch et al., 2006). Amino acid withdrawal inter-
feres with the interaction of Rheb and TOR-raptor, indicating
that the Rheb-TOR interaction is responsible for the sensitiv-
ity of the TOR pathway to the presence or absence of amino
acids. Rheb is negatively regulated by the Tuberous sclerosis com-
plex proteins, composed of TSC1 (hamartin) and TSC2 (tuberin)
(Manning and Cantley, 2003). The disease known as tuber-
ous sclerosis is an autosomal dominant disorder associated with
benign tumors that is the result of inherited mutations in the
TSC1 or TSC2 genes. PKB phosphorylates TSC2 (Choo et al.,
2006) inhibiting the function of the TSC1-TSC2 complex (Choo
et al., 2006). Thus PKB signaling releases the inhibition of Rheb
and activates TOR signaling. The TSC complex is necessary for
the downregulation of TOR in response to hypoxia (Ellisen,
2005).
Many growth factors signal through the MAPK cascade. The
MAPK cascade is a highly conserved signaling pathway and is
a major regulator of growth and differentiation. MAPK cas-
cades typically have three levels (Huang and Ferrell, 1996). The
terminal member of the cascade is a MAPK (e.g., ERK, JNK,
p34, p42), which is activated by a MAPK kinase (MAPKK: e.g.,
MEK, EKK), which in turn is activated by a MAPKK kinase
(MAPKKK; e.f Raf, Mos). The MAPKKK can be activated in sev-
eral ways: most commonly by external signals such as epidermal
growth factor (EGFR) via a G-protein-coupled receptor complex,
and also by insulin signaling (Oldham and Hafen, 2003). The
terminal MAPK translocates to the nucleus where it phosphory-
lates transcriptional regulators for protein synthesis, growth and
differentiation.
STRUCTURE OF THE MODEL
In modeling this system we omit consideration of multiple phos-
phorylation steps, equilibrium reactions between kinases and
phosphatases, and translocations between cytosolic and nuclear
compartments. We consider only the activity level of the various
kinases and other components in the network. Unlike a Boolean
network, in which each element is either on or off, each element in
our scheme can have a continuum of activity between zero (inac-
tive) and one (maximum activity). The activity level of a node
in the network is a function of activating and inhibitory inputs.
We assume that activation follows a sigmoid trajectory, with little
activity at low input levels and saturating at high input levels.
The time-dependent activation equation for each node in the
network is the logistic
dy
dt
= ay(1 − y/b) (1)
where a is the rate of increase and b is the ceiling. Over time y lev-
els off at the value of b. Graphs of this time-dependent response,
and the effects of parameters a and b, are shown in Figure 2. The
value of b is a sigmoidal function of input, so that at low input
b (and consequently the maximum value of y) is small and rises
sigmoidally to a value of 1 as input increases. The equation for b
is a solution to the logistic, as follows
b = 1
1 + e− input−0.5c
(2)
where the 0.5 ensures the inflection point is at an input of 0.5,
and c sets the steepness of the transition, with smaller values pro-
ducing a more switch-like transition. The curves are symmetrical
around the inflection point. Graphs of this function for different
values of c are shown in Figure 3.
This pair of functions thus scales the value of y between 0
and 1, for a range of inputs that are scaled from 0 to1. The value
of y then becomes part of the input to the next step in the net-
work. Multiple (activating and inhibiting) inputs are summed as
follows: activators are averaged, and inhibitors are averaged and
subtracted from the activator mean.
Thus the input function looks like:
input = 1
n
n∑
i= 1
Wi
∗activatori − 1
m
m∑
i= 1
Wi
∗inhibitori, (3)
where Wi represent the weight of each activator or inhibitor. The
weights were chosen in such a way that the model reproduced
experimental data (Sedaghat et al., 2002; Danielsson et al., 2005).
FIGURE 2 | Time-dependent sigmoids (effect of parameters a and b).
Parameter a controls when the response attains saturation. Parameter b
controls the saturation point of the response.
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Values for the weights used in the present model, and the values of
all other parameters, are given in Table 1. There is no information
available on how multiple inputs are integrated, so we assume
a linear weighing scheme. The linear weighing scheme is there-
fore a hypothesis about how things could work, and as more data
become available it might have to be modified. We show that
the selection of weights and parameter values in Table 1 is also
sufficient to enable the model to reproduce a broad diversity of
experimental results.
The model consists of a set of coupled equations of the form
of Equation (1), one for each node in the network, with the val-
ues of b represented by Equation (2) and the inputs by Equation
(3). Most nodes are inactive unless activated, with the exception
of TOR, Rheb and TSC, which are constitutively active unless
inhibited. There are three external inputs: insulin, amino acids,
and growth factors that activate the MAPK cascade.
FIGURE 3 | Graphs of the value of b in Equation (2) as a function
parameter c. Parameter c controls the steepness of the sigmoid; the
smaller c is, the steeper the sigmoid.
RESULTS AND DISCUSSION
THE MAPK CASCADE AND SWITCH-LIKE BEHAVIOR
The MAPK phosphorylation cascade is one of the most preva-
lent signal transduction pathways, typically mediating between
a G-protein coupled surface receptor for a growth signal and a
transcriptional regulator that affects growth and cell prolifera-
tion. TheMAPK cascade can also be activated by insulin signaling
via the stimulation of the upstream kinase (e.g., Raf) via INR
(Oldham and Hafen, 2003). MAPK cascades have either three
or four levels with multiple phosphorylation steps at each level
(Huang and Ferrell, 1996). This structure sharpens the response
to a graded signal and makes the response increasingly more
switch-like at successively lower levels of the cascade (Huang and
Ferrell, 1996). In our model we do not explicitly model phos-
phorylation and dephosphorylation steps but instead model the
transition between an active and inactive kinase, using our sig-
moid formalism. Figure 4 illustrates the behavior of the 3-step
MAPK cascade we model to a linear graded input and shows
the expected switch-like behavior. The increasing steepness of the
response emerges from the fact that each lower step in the cascade
is responding to a sigmoidal input in a sigmoidal fashion. MAPK
cascades may have a negative feedback regulation by the last to the
first member in the cascade (Brondello et al., 1997; Keyse, 2000;
Kholodenko, 2000; Asthagiri and Lauffenburger, 2001; Nijhout
et al., 2003). Figure 5 shows the dose-response behavior of our
model when such a feedback is included, using the same kinetic
parameters as in Figure 4. Including the feedback makes the
response of the terminal kinase less switch-like.
INSULIN DOSE-RESPONSE
In our model insulin concentration can vary from zero (no
insulin) to 1 (maximum or saturating insulin). Dose-response
curves are typically hyperbolic on linear axes and sigmoidal when
plotted on a logarithmic x-axis. In our scheme all axes are lin-
ear and the linear x-axis must therefore represent a logarithmic
Table 1 | Parameter values and input functions used in the model.
Variable Activators Inhibitors Input function c a
INR Insulin, FOXO (insulin.*1+ FOXO.*0.144)./2 0.15 1
IRS INR PKB, S6K INR.*2−(0.1.*PKB + 0.2.*S6K)./2 0.15 1
PI3K IRS IRS.*1 0.2 1
PIP3 PI3K PI3K.*1 0.2 1
PKC PIP3 PIP3.*1 0.25 1
PKB PIP3 PKC PIP3.*1−0.5.*PKC 0.15 1
GLUT4 PKC, PKB (PKC.*3 + PKB.*4)./2 0.05 1
TSC Constitutive PKB 1–0.7.*PKB 0.1 0.5
Rheb Constitutive TSC 1–0.5.*TSC 0.1 1
TOR Rheb, amino acids, PKB FOXO (rheb.*3 + 1.*aminoAcids + 2.*PKB)./3–2*FOXO) 0.1 1
S6K TOR, PKC (TOR.*1.5 + PKC.*0.5)./2 0.1 1
Protein synthesis TOR, S6K, MAPKKK (S6K.*1 + TOR.*1 + MAPK.*1.2)./3 0.1 1
FOXO Constitutive PKB 1–0.9.*PKB 0.1 0.5
MAPK MAPKK MAPKK 0.1 1
MAPKK MAPKKK MAPKKK 0.15 1
MAPKKK INR, EGF growth factors MAPK (egfsignal + PI3K)/2–0.3.*MAPK 0.2 1
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FIGURE 4 | MAPK cascade simulation shows that the signal becomes
more switchlike as it travels down the MAPK cascade, as shown in
Huang and Ferrell (1996).
FIGURE 5 | MAPK cascade with negative feedback from MAPK to
MAPKKK. The negative feedback makes the response less switchlike.
insulin concentration scale. The dose-response of INR phospho-
rylation to insulin in experimental settings spans about 4-orders
of magnitude of insulin concentration (from 10−11 to 10−7 M)
(Stagsted et al., 1993; Kurtzhals et al., 2000; Sedaghat et al.,
2002; Danielsson et al., 2005). Thus on our linear scale 0.25
units correspond approximately to one decade on a logarithmic
scale.
Dose-response curves for active IRS, active PI3K, PKB,
GLUT4, and MAPK, as functions of insulin concentra-
tion are shown in Figure 6. The activities are scaled to
the maximal response and these relative responses closely
resemble the empirical data of Stagsted et al. (1993);
Danielsson et al. (2005), except for the response of PKB,
which in experimental data appears to saturate at some-
what lower concentrations of insulin than it does in our
model.
FIGURE 6 | Insulin dose response curves of various components of the
insulin and MAPK signaling pathways replicating (Stagsted et al.,
1993; Sedaghat et al., 2002; Danielsson et al., 2005). The GLUT4
transporters are the most sensitive to insulin signaling, and achieve their
maximum response at relatively low levels of insulin stimulation (0.4).
AMINO ACIDS, PROTEIN SYNTHESIS, AND TOR KNOCKOUT
Normal growth requires, in addition to insulin signaling, amino
acid signaling through TOR (Hay and Sonenberg, 2004; Martin
and Hall, 2005; Kim and Guan, 2011). In our model, amino
acids activate TOR/Raptor directly. In addition, insulin signaling
is known to stimulate the import into the cell of neutral amino
acids that are handled by the system-A transporter (Kilberg, 1982;
McDowell et al., 1998; Biolo et al., 1999; Jones et al., 2006). The
exact mechanism is not fully understood, and here we model it
as an effect of PKC. Thus growth is regulated by three interact-
ing pathways, MAPK, insulin, and TOR (Figure 7). MAPK and
insulin signaling can stimulate growth autonomously, but TOR
requires activation by insulin signaling in order to be sensitive to
stimulation by amino acids.
PTEN, A TUMOR SUPPRESSOR GENE
PTEN is a well-known tumor suppressor gene, and many can-
cers are associated with a reduction in PTEN activity (Leslie and
Downes, 2004; Nassif et al., 2004; Song et al., 2012).We showwith
our model that knocking out PTEN increases protein synthesis
at lower insulin levels (Figure 8A), and increases insulin sensitiv-
ity of GLUT4 activation (Figure 8B). This is consistent with data
showing that PTEN haploinsufficiency increases the probability
of developing tumors, and also increases insulin sensitivity (pro-
tects against diabetes) (Pal et al., 2013). Overexpression of PTEN,
by contrast, greatly reduces both proteins synthesis and GLUT4
activation, consistent with its role as a tumor suppressor (Zhao
et al., 2005).
FOXO: A REGULATOR OF PHENOTYPIC PLASTICITY?
Insulin signaling regulates growth and size in response to
nutrition (Oldham and Hafen, 2003; Grewal, 2009), but few mor-
phological traits scale isometrically: morphological traits com-
monly scale hyper- or hypo-allometrically with size. These scaling
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FIGURE 7 | (A) Protein synthesis as a function of MAPK and insulin. MAPK
and insulin act synergistically, and the maximum protein synthesis occurs
when both pathways are activated. Nevertheless, at low levels of MAPK
signaling, insulin is still able to stimulate protein synthesis. (B) Same figure
but with TOR knockout. The effect of the TOR knockout on protein synthesis
is only noticeable when there is weak MAPK signaling (right corner of the
figure); when TOR is knocked out and MAPK signaling is low, insulin alone
cannot stimulate protein synthesis.
FIGURE 8 | Effect of PTEN over expression and knock-down on the
sensitivity of insulin stimulated protein synthesis (A) and GLUT4
activation (B). PTEN overexpression reduces the maximum level of protein
synthesis, and completely abrogates the response of GLUT4 to insulin
stimulation. PTEN underexpression does not have as dramatic an effect,
but does increase the sensitivity of protein synthesis in response to insulin
especially at high insulin levels. In contrast, the stimulatory effect of PTEN
underexpression on GLUT 4 sensitivity is mainly observed at low insulin
levels.
relationships must arise from differential sensitivity of tissues to
systemic growth factors and nutritional availability.
Recent evidence indicates that differential trait growth is a con-
sequence of differential sensitivity to insulin, regulated by FOXO
(Tang et al., 2011; Snell-Rood and Moczek, 2012; Shingleton and
Frankino, 2013). Genitalia of flies (Tang et al., 2011) and of bee-
tles (Snell-Rood and Moczek, 2012) are relatively insensitive to
nutrition (or lack thereof). In contrast, wings and horns are more
sensitive to nutrition (Tang et al., 2011; Emlen et al., 2012). In
beetles, knockdown of FOXO using RNAi causes slight but signif-
icant overgrowth of the genitalia (Snell-Rood andMoczek, 2012),
indicating that in normal growth conditions, FOXO represses
insulin-stimulated growth in that tissue. Loss of FOXO causes
genitalia and wings to both scale isometrically with body size
(Tang et al., 2011), indicating that FOXO is necessary to maintain
trait-specific sensitivity to insulin.
In normal growth conditions, increased expression of FOXO
decreases body and organ size (Jünger et al., 2003; Puig et al.,
2003). In poor nutritional conditions or in Insulin Receptor (InR)
mutants, growth is inhibited, and this reduction in growth is
partially rescued by knocking out FOXO (Tang et al., 2011). A
similar phenomenon has been observed in C. elegans: mutants
in Daf-2 (INR homolog) arrest growth at the dauer stage, but
null mutations in Daf-16 (FOXO homolog) suppress the effects
of mutations in Daf-2, rescuing growth (Ogg et al., 1997). This
suggests that in both flies and worms, FOXO knockout rescues
InR mutants.
We tested the model against these predictions. Specifically we
tested the following predictions: (1) FOXO overexpression should
decrease body size/protein synthesis under any nutritional condi-
tion. Indeed, Figure 9 shows the result of overexpressing FOXO:
protein synthesis is reduced as a function of all insulin inputs,
but the effect is particularly strong at high insulin levels (in good
nutritional conditions). (2) FOXO knockout. Under high insulin
signaling conditions/high nutritional conditions, FOXO knock-
out should slightly stimulate protein synthesis. Under low insulin
signaling conditions, FOXO knockout flies should increase pro-
tein synthesis relative to wild type flies. Indeed, Figure 9 shows
the result of knocking out FOXO. Protein synthesis is increased at
low insulin levels, indicating that FOXO knockout compensates
for poor nutritional conditions. In high nutritional conditions,
protein synthesis is close to wild type, if not slightly enhanced,
consistent with the slight increase in size of the beetle genitalia
in FOXO knock-down animals (Snell-Rood and Moczek, 2012).
(3) FOXO and InR double knockout. InR knockout should reduce
protein synthesis, and this reduction should be partially rescued
by the FOXO knockout. Indeed, Figure 10 shows that protein syn-
thesis is strongly reduced in the InR knockout and that protein
synthesis is rescued in the double FOXO-InR knockout. Thus,
the model is consistent with previous observations and appears
to summarize the developmental mechanism by which FOXO
regulates sensitivity to insulin input.
HYPOXIA
Hypoxia decreases body size in a variety of species, although
hyperoxia often does not have a symmetrical effect (Harrison
et al., 2010; Harrison and Haddad, 2011). The mechanisms by
which hypoxia affect growth and size are incompletely under-
stood. Oxygen affects multiple physiological processes and is
sensed by a variety of signaling pathways, including the Hypoxia
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Inducible Factor (HIF) (Gorr et al., 2006) and nitric oxide
(NO)/cyclic GMP pathway (Davies, 2000).
HIF and HIF targets interact with components of the insulin
signaling pathway; specifically, oxygen affects the inhibition of
TSC by Akt (Brugarolas et al., 2004; Deyoung et al., 2008). In nor-
moxic conditions, insulin causes Akt to phosphorylate TSC2. This
FIGURE 9 | Effect of overexpression and knockout of FOXO on
insulin-stimulated protein synthesis. FOXO knockout increases protein
synthesis especially at low levels of insulin stimulation. On the other hand,
FOXO overexpression primarily affects protein synthesis when insulin
signaling is high. These two observations can be explained by the fact that
FOXO inhibits TOR and this inhibition is inhibited by PKB when insulin is
high. At low insulin levels, FOXO should inhibit TOR and protein synthesis,
and hence the knockout relieves this inhibition. At high insulin levels, FOXO
should be inhibited by PKB and therefore not have an inhibitory effect on
protein synthesis, but FOXO overexpression prevents PKB from entirely
relieving the constitutive inhibition of protein synthesis by FOXO.
FIGURE 10 | FOXO knockout rescues the growth defects of INR
mutants. In an INR deficient mutant, protein synthesis is severely
depressed and regulated primarily by MAPK (activation of MAPK is set at
0.1 in this experiment). FOXO knockout alone has no effect on protein
synthesis, but can partially rescue protein synthesis in an INR knockout.
Protein synthesis values are scaled to those of a “wild type.” Input into the
MAPK pathway is 0.1.
phosphorylation promotes the binding of TSC2 to its inhibitor
14-3-3 (Deyoung et al., 2008), thereby inhibiting the dimerization
and activation of the TSC1/2 complex. In response to hypoxia,
REDD1 is induced and sequesters the inhibitor 14-3-3. This
releases TSC2 to dimerize with TSC1 and thus promote TSC1/2
function and inhibition of TOR. Thus, in low oxygen conditions,
protein synthesis is reduced. Because TSC1/2 is already consti-
tutively active at low insulin signaling, the effects of hypoxia on
TSC1/2 will be most apparent at high levels of insulin signaling.
Our model shows that low oxygen levels decrease protein
synthesis, and the effect is strongest at high levels of insulin
(Figure 11). The reason for this effect is that at low levels of
insulin, Akt is not stimulated, so Akt is not strongly inhibit-
ing TSC, and the removal of this inhibition has no effect.
Hypoxia has the strongest effect on growth when insulin sig-
naling (and Akt) activity is high. In our model, hyperoxia only
marginally stimulates protein synthesis beyond its normoxic
range. This is consistent with the observation that hyperoxia
does not have strong stimulating effects on growth and size in
a variety of species (including Drosophila and Manduca). The
fact that the effect of hypoxia is a disinhibition could possi-
bly explain the asymmetrical response of growth to hypoxia and
hyperoxia. The double inhibition (Akt inhibits TSC, TSC inhibits
TOR) is relieved in hypoxia, but it is unclear whether hyper-
oxia will significantly enhance the inhibition of TSC by Akt. If
this inhibition is already strong in normoxia, then hyperoxia pro-
vides no additional benefit. This could explain the asymmetrical
growth response to hypoxia/hyperoxia observed in many insect
species.
FIGURE 11 | Effects of oxygen on protein synthesis (growth), mediated
by the insulin and TOR signaling pathways are most strongly
observed at high insulin signaling levels (>0.7). This suggests that in
poor nutritional conditions, hypoxia or hyperoxia are unlikely to have strong
effects on growth and size; only in good nutritional conditions will oxygen
show an effect. Hypoxia decreases the rate of insulin-stimulated protein
synthesis. Hyperoxia causes protein synthesis to reach its saturating rate at
a slightly lower level of insulin signaling, so it has a slight stimulatory effect
for insulin between 0.7 and 0.8. At levels of insulin signaling >0.8,
hyperoxia provides no additional stimulation of growth because growth rate
has attained its maximum.
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CONCLUSIONS AND SIGNIFICANCE
We have developed a simple and easy-to-implement
mathematical model for investigating the logical sufficiency and
qualitative behavior of signaling pathways. This model is par-
ticularly useful to simulate experimental data that are scaled or
normalized, which are the norm in studies of signaling pathways.
We use this model to study the behavior of an integrated insulin-
TOR-MAPK pathway and compare the results to a broad diversity
of experimental data.
Our model provides a simple and easy-to-implement tool for
investigating the dynamics of a system that integrates multiple
graded inputs and produces a specific output from a set of pos-
sible responses. The kinetics of signal transduction pathways are
inherently non-linear and our model embraces this nonlinearity
by assuming that the strength of a response (e.g., the activation
of a kinase), is a sigmoid function of the combined activating and
inhibitory inputs, so that at low input there is no response and
at high input the response saturates. The model correctly simu-
lates the ultrasensitivity and switch-like behavior of the MAPK
cascade. We show that the model also correctly simulates pub-
lished dose-response curves of INR, PKC, and GLUT4 to insulin
input.
We used the model to simulate several experimental observa-
tions. TOR has been widely described as a “sensor” for amino
acid input and inactivation of TOR by mutation or by rapamycin
reduces growth and body size. When we inactivated TOR in our
model we found a reduction in insulin-induced protein synthesis
(which we use as a proxy for growth), but, as expected, no effect
on MAPK-induced protein synthesis. Thus in cases where growth
is controlled jointly by insulin and MAPK signaling, the effect of
TOR will depend on the relative role of insulin.
Growth depends not only on hormone signaling but also
on an adequate supply of amino acids. Amino acids can
directly stimulate the TOR branch of the insulin signaling path-
way, but insulin signaling also enhances the uptake of certain
amino acids. In our model we found a hyperbolic relation-
ship between amino acid availability and S6K activity in the
presence of constant insulin signaling, but no unique effect of
amino acids on protein synthesis. Protein synthesis required
both insulin and amino acids, but increasing amino acid levels
did not increase protein synthesis under constant insulin. In
accord with experimental findings we found that overexpres-
sion of FOXO decreased insulin-stimulated protein synthe-
sis, whereas a FOXO knockout made protein synthesis more
sensitive to insulin levels. Likewise, knockout of FOXO can
rescue protein synthesis deficiency caused by an INR knock-
out. Finally, knockout of PTEN and TSC, both well-known
tumor suppressors, greatly increased insulin-driven protein
synthesis.
The network we simulated here leaves out most of the bio-
chemical details of the insulin and MAPK signaling pathways,
and thus can only simulate the qualitative behavior of the net-
work. Even so, the fit to experimental data is excellent (which are
typically also qualitative), which suggest that the structure of the
network, and the way in which we modeled it, are sufficient to
explain the phenomena we studied here.
A natural question that arises when developing amathematical
model is whether all the necessary players and all their inter-
actions have been included. No network is ever complete, and
investigators continually find new players and new interactions.
But it is not always clear whether each newly discovered item is
critical for the normal operation of the network, or whether it is
important only under a particular set of conditions, or whether
it has only a minor effect. Moreover, investigators often publish
small abbreviated models of hypothetical mechanism suggested
by their experimental data but seldom investigate whether the
proposed mechanism is sufficient to produce the observed behav-
ior. The current modeling paradigm provides a simple tool to
do such a test. One of the uses of a mathematical model is to
investigate whether such a hypothetical network actually has the
expected behavior. A mathematical model can say whether the
system that is being modeled is sufficient to produce the observed
biological behaviors found under experimental conditions. And
when this is not the case, experimentation with the model can
often lead the way to discovery of what is missing.
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